✨ Your Portfolio is fetched and updated from zerodha.
Nano
Market Cap
₹119 Cr.
P/E
12.40

Key Ratios

Market cap
Market cap
119 Cr
PE
PE
12.40
Prom Holding
Prom Holding
69.98 %
ROE (%)
ROE (%)
15.41
ROCE (%)
ROCE (%)
25.04
Div Yield (%)
Div Yield (%)
-
Sales
Sales
133 Cr
OPM (%)
OPM (%)
10.19 %
Debt to Equity
Debt to Equity
0.40
About
Zenith Drugs Limited is a pharmaceutical manufacturing and trading company specializing in hig… Read more
Low
66
52W Range
High
143
  • Zenith Drugs
  • Mangalam Drugs&Org.
  • Amwill Health Care

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Zenith Drugs Ltd. Business

Zenith Drugs Limited is a pharmaceutical manufacturing and trading company. It has a manufacturing unit, dedicated to ensuring the highest quality standards when it comes to manufacturing of medicines. It is specialized in manufacturing high quality and affordable Medicines to support its patients in need. The company is also into Generic Medicines and Generic Medicines are cost effective. Since its inception, the company has focused on building a strong foundation and laying the groundwork for its future growth and success. With dedication and strategic planning, it managed to establish a reputable presence in the pharmaceutical industry.

Zenith Drugs major competitors are Mangalam Drugs&Org., Amwill Health Care, Auro Laboratories, Denis Chem Lab, Smruthi Organics, Rajnish Wellness, Mercury Laboratories.
Market Cap of Zenith Drugs is ₹119 Crs.
While the median market cap of its peers are ₹121 Crs.

Zenith Drugs seems to be less financially stable compared to its competitors.
Altman Z score of Zenith Drugs is 3.18 and is ranked 6 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material